Home▸Menopause Hormone Replacement Therapy▸Menopausal Hormone Therapy Risk-Benefit Simulator

🌸 Menopausal Hormone Therapy Risk-Benefit Simulator

This simulation evaluates the risks and benefits of menopausal hormone therapy, helping healthcare providers make informed decisions about treatment options.

Menopause Hormone Replacement Therapy2DModerate60 FPS
Menopausal Hormone Therapy Risk-Benefit Simulator ↗ Open standalone

Vasomotor Symptom Relief With Hormone Therapy

Placeholder: HRT is the most effective treatment for hot flashes.

  • ~75%: Hot flash reduction (placeholder figure)
  • Improved: Sleep quality (placeholder figure)
  • High: Genitourinary relief (placeholder figure)
  • 2–4 wks: Onset of effect (placeholder figure)

Mechanism of symptomatic benefit

Placeholder: estrogen stabilizes thermoregulatory center function.

The Timing Hypothesis — Cardiovascular Risk Window

Placeholder: CV risk-benefit shifts with years since menopause onset.

  • Favorable: Window <10 yrs (placeholder figure)
  • Cautionary: Window >10 yrs (placeholder figure)
  • Transdermal lower: Route effect (placeholder figure)
  • Age-stratified: WHI reanalysis (placeholder figure)

Timing hypothesis mechanism

Placeholder: early initiation favors vascular health outcomes.

Breast Cancer Risk Considerations by Regimen

Placeholder: combined therapy carries different risk than estrogen-alone.

  • Lower risk: Estrogen-alone (placeholder figure)
  • Modest increase: Combined EPT (placeholder figure)
  • Risk rises w/ time: Duration effect (placeholder figure)
  • Declines after stop: Risk reversibility (placeholder figure)

Regimen-dependent risk profile

Placeholder: progestin component modifies breast cancer risk.

Bone Mineral Density Protection and Fracture Reduction

Placeholder: HRT preserves bone density and lowers fracture risk.

  • Reduced: Hip fracture (placeholder figure)
  • Reduced: Vertebral fracture (placeholder figure)
  • Preserved: BMD change (placeholder figure)
  • While on therapy: Effect duration (placeholder figure)

Skeletal protective mechanism

Placeholder: estrogen suppresses osteoclast-mediated bone resorption.

Shared Decision-Making for Individualized HRT Use

Placeholder: decisions weigh symptoms, age, and personal risk factors.

  • Age at start: Key factor (placeholder figure)
  • Baseline risk: Key factor (placeholder figure)
  • Symptom severity: Key factor (placeholder figure)
  • Annual: Review interval (placeholder figure)

Balancing individual risk and benefit

Placeholder: shared decision-making integrates all risk-benefit inputs.

Placeholder: individualized risk-benefit assessment guides HRT decisions.
⚙ Under the hood

This simulation evaluates the risks and benefits of menopausal hormone therapy, helping healthcare providers make informed decisions about treatment options.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)